Generation Investment Management LLP Takes $356.30 Million Position in The Cooper Companies, Inc. $COO

Posted by on Aug 20th, 2026

Generation Investment Management LLP acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,968,673 shares of the medical device company’s stock, valued at approximately $356,304,000. Cooper Companies makes up approximately 3.5% of Generation Investment Management LLP’s investment portfolio, making the stock its 10th largest position. Generation Investment Management LLP owned about 2.55% of Cooper Companies as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. New York Life Investment Management LLC lifted its stake in Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares in the last quarter. Root Financial Partners LLC grew its holdings in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares during the last quarter. Essential Partners LLC increased its position in Cooper Companies by 23.4% during the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock worth $62,000 after buying an additional 166 shares in the last quarter. Allworth Financial LP increased its position in Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after buying an additional 167 shares in the last quarter. Finally, SJS Investment Consulting Inc. raised its holdings in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

COO stock opened at $76.73 on Thursday. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83. The stock’s fifty day simple moving average is $71.59 and its 200-day simple moving average is $71.16. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $14.96 billion, a price-to-earnings ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.During the same quarter in the previous year, the business earned $0.96 earnings per share. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently issued reports on COO shares. Wells Fargo & Company restated a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. UBS Group initiated coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price for the company. BNP Paribas Exane reduced their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Robert W. Baird decreased their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Finally, Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and an average target price of $81.64.

View Our Latest Stock Analysis on COO

About Cooper Companies

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Featured Articles

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.